Cargando…

Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer

Androgen-ablation therapies, which are the standard treatment for metastatic prostate cancer, invariably lead to acquired resistance. Hence, a systematic identification of additional drivers may provide useful insights into the development of effective therapies. Numerous microRNAs that are critical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Mengzhu, Liu, Haiyue, Zhang, Liwen, Chang, Hongyuan, Liu, Yuwei, Du, Shaowei, Yang, Yingqun, Wang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394245/ https://www.ncbi.nlm.nih.gov/pubmed/28397780 http://dx.doi.org/10.1038/ncomms14917

Ejemplares similares

Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition
por: Chang, Hongyuan, et al.
Publicado: (2016)

MicroRNAs Associated with Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2011)

MicroRNAs Show Mutually Exclusive Expression Patterns in the Brain of Adult Male Rats
por: Olsen, Line, et al.
Publicado: (2009)

Dysregulation of MicroRNAs in cancer
por: Chen, Pai-Sheng, et al.
Publicado: (2012)

Testing mutual exclusivity of ETS rearranged prostate cancer
por: Svensson, Maria A, et al.
Publicado: (2011)

A Network-Centric Framework for the Evaluation of Mutual Exclusivity Tests on Cancer Drivers
por: Ahmed, Rafsan, et al.
Publicado: (2021)

Algorithms for mutual exclusion /
por: Raynal, Michel
Publicado: (1986)

MicroRNA Dysregulation in Prostate Cancer
por: Schitcu, Vlad Horia, et al.
Publicado: (2022)

Identifying Driver Genomic Alterations in Cancers by Searching Minimum-Weight, Mutually Exclusive Sets
por: Lu, Songjian, et al.
Publicado: (2015)

Transcriptomic heterogeneity of driver gene mutations reveals novel mutual exclusivity and improves exploration of functional associations
por: Lan, Yujia, et al.
Publicado: (2021)

The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer—An Update
por: Choi, Pui-Wah, et al.
Publicado: (2022)

SSA-ME Detection of cancer driver genes using mutual exclusivity by small subnetwork analysis
por: Pulido-Tamayo, Sergio, et al.
Publicado: (2016)

Mutually Exclusive Uncertainty Relations
por: Xiao, Yunlong, et al.
Publicado: (2016)

Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT
por: Liu, Yuwei, et al.
Publicado: (2019)

Author Correction: Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT
por: Liu, Yuwei, et al.
Publicado: (2019)

Emerging Mutual Regulatory Roles between m(6)A Modification and microRNAs
por: Mei, Zongqin, et al.
Publicado: (2023)

Identification of dysregulated microRNAs in canine malignant melanoma
por: Ushio, Norio, et al.
Publicado: (2019)

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
por: Catanesi, Mariano, et al.
Publicado: (2020)

Dysregulated CD4+ T Cells and microRNAs in Myocarditis
por: Wang, Jing, et al.
Publicado: (2020)

MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
por: Xiang, Chunchen, et al.
Publicado: (2019)

Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis
por: Wang, Lin, et al.
Publicado: (2020)

Identifying Mutually Exclusive Gene Sets with Prognostic Value and Novel Potential Driver Genes in Patients with Glioblastoma
por: Gao, Qian, et al.
Publicado: (2019)

Modeling Mutual Exclusivity of Cancer Mutations
por: Szczurek, Ewa, et al.
Publicado: (2014)

The landscape of human mutually exclusive splicing
por: Hatje, Klas, et al.
Publicado: (2017)

MicroRNAs: emerging driver of cancer perineural invasion
por: Zhang, Mei, et al.
Publicado: (2021)

RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells
por: Bosia, Carla, et al.
Publicado: (2017)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

Variable window binding for mutually exclusive alternative splicing
por: Anastassiou, Dimitris, et al.
Publicado: (2006)

Dysregulation of MicroRNAs in Colonic Field Carcinogenesis: Implications for Screening
por: Kunte, Dhananjay P., et al.
Publicado: (2012)

Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer
por: Huang, Po-Shuan, et al.
Publicado: (2021)

MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis
por: Ghasemi, Fahimeh, et al.
Publicado: (2022)

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells
por: Evers, Lara, et al.
Publicado: (2023)

An evolutionarily conserved mutual interdependence between Aire and microRNAs in promiscuous gene expression
por: Ucar, Olga, et al.
Publicado: (2013)

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
por: Li, Zheqi, et al.
Publicado: (2022)

Random walks on mutual microRNA-target gene interaction network improve the prediction of disease-associated microRNAs
por: Le, Duc-Hau, et al.
Publicado: (2017)

Dysregulation of cell cycle related genes and microRNAs distinguish the low- from high-risk of prostate cancer
por: Wen, Jiling, et al.
Publicado: (2014)

Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease
por: Zhong, Zhixiong, et al.
Publicado: (2018)

Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf
por: Siverskog, Jonathan, et al.
Publicado: (2020)

Biological impact of mutually exclusive exon switching
por: Lam, Su Datt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mfhsu7gg8su417i38a2msvdj0o